Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The N501Y mutation in SARS-CoV-2 spike leads to morbidity in obese and aged mice and is neutralized by convalescent and post-vaccination human sera
Raveen Rathnasinghe, Sonia Jangra, Anastasija Čupić, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 132

Showing 26-50 of 132 citing articles:

Evolution of nasal and olfactory infection characteristics of SARS-CoV-2 variants
Mengfei Chen, Andrew Pekosz, Jason Villano, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 8
Open Access | Times Cited: 17
Increased transmission of SARS-CoV-2 lineage B.1.1.7 (VOC 2020212/01) is not accounted for by a replicative advantage in primary airway cells or antibody escape
Jonathan C. Brown, Daniel H. Goldhill, Jie Zhou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 96
HIV-1 and SARS-CoV-2: Patterns in the evolution of two pandemic pathogens
Will Fischer, Elena E. Giorgi, Srirupa Chakraborty, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 7, pp. 1093-1110
Open Access | Times Cited: 90
Will Mutations in the Spike Protein of SARS-CoV-2 Lead to the Failure of COVID-19 Vaccines?
Zaixing Jia, Wenping Gong
Journal of Korean Medical Science (2021) Vol. 36, Iss. 18
Open Access | Times Cited: 87
SARS-CoV-2 variants show resistance to neutralization by many monoclonal and serum-derived polyclonal antibodies
Michael Diamond, Rita Chen, Xuping Xie, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 86
The SARS-CoV-2 B.1.1.529 Omicron virus causes attenuated infection and disease in mice and hamsters
Michael Diamond, Peter Halfmann, Tadashi Maemura, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 85
Potency of BNT162b2 and mRNA‐1273 vaccine‐induced neutralizing antibodies against severe acute respiratory syndrome‐CoV‐2 variants of concern: A systematic review of in vitro studies
Maryam Noori, Seyed Aria Nejadghaderi, Shahnam Arshi, et al.
Reviews in Medical Virology (2021) Vol. 32, Iss. 2
Open Access | Times Cited: 73
SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice
Emma S. Winkler, Rita E. Chen, Fahmida Alam, et al.
Journal of Virology (2021) Vol. 96, Iss. 1
Open Access | Times Cited: 72
Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge
Antonio E. Muruato, Michelle N. Vu, Bryan A. Johnson, et al.
PLoS Biology (2021) Vol. 19, Iss. 11, pp. e3001284-e3001284
Open Access | Times Cited: 71
Infection of wild-type mice by SARS-CoV-2 B.1.351 variant indicates a possible novel cross-species transmission route
Ting Pan, Ran Chen, Xin He, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 71
SARS-CoV-2: is there neuroinvasion?
Conor McQuaid, Molly Brady, Rashid Deane
Fluids and Barriers of the CNS (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 67
Nasally delivered interferon-λ protects mice against infection by SARS-CoV-2 variants including Omicron
Zhenlu Chong, Courtney E. Karl, Peter Halfmann, et al.
Cell Reports (2022) Vol. 39, Iss. 6, pp. 110799-110799
Open Access | Times Cited: 63
Mutations that adapt SARS-CoV-2 to mink or ferret do not increase fitness in the human airway
Jie Zhou, Thomas P. Peacock, Jonathan C. Brown, et al.
Cell Reports (2022) Vol. 38, Iss. 6, pp. 110344-110344
Open Access | Times Cited: 56
Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease
James Brett Case, Rita E. Chen, Longxing Cao, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 7, pp. 1151-1161.e5
Open Access | Times Cited: 55
The ins and outs of SARS-CoV-2 variants of concern (VOCs)
Mostafa Salehi‐Vaziri, Mehdi Fazlalipour, Seyed Mahmood Seyed Khorrami, et al.
Archives of Virology (2022) Vol. 167, Iss. 2, pp. 327-344
Open Access | Times Cited: 49
Limited extent and consequences of pancreatic SARS-CoV-2 infection
Verena van der Heide, Sonia Jangra, Phillip Cohen, et al.
Cell Reports (2022) Vol. 38, Iss. 11, pp. 110508-110508
Open Access | Times Cited: 48
mRNA vaccine-induced antibodies more effective than natural immunity in neutralizing SARS-CoV-2 and its high affinity variants
Yunkai Yu, Dominic Esposito, Zhigang Kang, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 43
Age-associated SARS-CoV-2 breakthrough infection and changes in immune response in a mouse model
Yanxia Chen, Can Li, Feifei Liu, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 368-383
Open Access | Times Cited: 41
Impaired immune response drives age-dependent severity of COVID-19
Julius Beer, Stefania Crotta, Angele Breithaupt, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 12
Open Access | Times Cited: 39
Boosting with Omicron-matched or historical mRNA vaccines increases neutralizing antibody responses and protection against B.1.1.529 infection in mice
Baoling Ying, Suzanne M. Scheaffer, Bradley Whitener, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 38
Understanding Mutations in Human SARS-CoV-2 Spike Glycoprotein: A Systematic Review & Meta-Analysis
Reetesh Kumar, Yogesh Srivastava, Pandiyan Muthuramalingam, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 856-856
Open Access | Times Cited: 28
SARS-CoV-2 N501Y variants of concern and their potential transmission by mouse
Hongyan Huang, Yichao Zhu, Zubiao Niu, et al.
Cell Death and Differentiation (2021) Vol. 28, Iss. 10, pp. 2840-2842
Open Access | Times Cited: 46
Reduced binding and neutralization of infection- and vaccine-induced antibodies to the B.1.351 (South African) SARS-CoV-2 variant
Venkata Viswanadh Edara, Carson Norwood, Katharine Floyd, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 42
Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit
Matthew D. Hall, James M. Anderson, Annaliesa S. Anderson, et al.
The Journal of Infectious Diseases (2021) Vol. 224, Iss. Supplement_1, pp. S1-S21
Open Access | Times Cited: 41
Kidney injury in COVID-19 patients, drug development and their renal complications: Review study
Zeynab Mohamadi Yarijani, Houshang Najafi
Biomedicine & Pharmacotherapy (2021) Vol. 142, pp. 111966-111966
Open Access | Times Cited: 41

Scroll to top